These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20963525)

  • 1. Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro?
    Rouse MS; Heijink A; Steckelberg JM; Patel R
    Clin Orthop Relat Res; 2011 May; 469(5):1466-9. PubMed ID: 20963525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro elution characteristics of antifungal-loaded PMMA bone cement and calcium sulfate bone substitute.
    Grimsrud C; Raven R; Fothergill AW; Kim HT
    Orthopedics; 2011 Aug; 34(8):e378-81. PubMed ID: 21815580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.
    Calvo E; Pastor FJ; Salas V; Mayayo E; Guarro J
    Mycopathologia; 2012 Apr; 173(4):251-7. PubMed ID: 22139415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults.
    Crandon JL; Banevicius MA; Fang AF; Crownover PH; Knauft RF; Pope JS; Russomanno JH; Shore E; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5102-7. PubMed ID: 19770284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
    Seyedmousavi S; Brüggemann RJ; Melchers WJ; Rijs AJ; Verweij PE; Mouton JW
    J Antimicrob Chemother; 2013 Feb; 68(2):385-93. PubMed ID: 23129729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and pharmacokinetics of coadministered voriconazole and anidulafungin.
    Dowell JA; Schranz J; Baruch A; Foster G
    J Clin Pharmacol; 2005 Dec; 45(12):1373-82. PubMed ID: 16291712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial.
    Mootsikapun P; Hsueh PR; Talwar D; Co VM; Rajadhyaksha V; Ong ML
    BMC Infect Dis; 2013 May; 13():219. PubMed ID: 23676114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America.
    Nucci M; Colombo AL; Petti M; Magana M; Abreu P; Schlamm HT; Sanchez SP
    Mycoses; 2014 Jan; 57(1):12-8. PubMed ID: 23710653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.
    Petraitis V; Petraitiene R; Hope WW; Meletiadis J; Mickiene D; Hughes JE; Cotton MP; Stergiopoulou T; Kasai M; Francesconi A; Schaufele RL; Sein T; Avila NA; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2382-91. PubMed ID: 19307368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
    Perkhofer S; Lass-Flörl C
    Expert Opin Investig Drugs; 2009 Sep; 18(9):1393-404. PubMed ID: 19656074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: a combination study design in support of a Paediatric Investigation Plan.
    Cross DM; Chmielewski G; Lewis EM; Liu L; Modesitt MS; Ripp SL; Sawaryn CM; Bowman CJ
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):29-39. PubMed ID: 22343256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation.
    El-Hadidy GN; Ibrahim HK; Mohamed MI; El-Milligi MF
    Drug Dev Ind Pharm; 2012 Jan; 38(1):64-72. PubMed ID: 21696340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole is delivered from antifungal-loaded bone cement.
    Miller RB; McLaren AC; Pauken C; Clarke HD; McLemore R
    Clin Orthop Relat Res; 2013 Jan; 471(1):195-200. PubMed ID: 22782573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of daptomycin from polymethylmethacrylate beads in a continuous flow chamber.
    Hall EW; Rouse MS; Jacofsky DJ; Osmon DR; Hanssen AD; Steckelberg JM; Patel R
    Diagn Microbiol Infect Dis; 2004 Dec; 50(4):261-5. PubMed ID: 15582299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
    Serrano Mdel C; Valverde-Conde A; Chávez M M; Bernal S; Claro RM; Pemán J; Ramirez M; Martín-Mazuelos E
    Diagn Microbiol Infect Dis; 2003 Feb; 45(2):131-5. PubMed ID: 12614985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bead size and polymerization in PMMA bone cement on vancomycin release.
    Shinsako K; Okui Y; Matsuda Y; Kunimasa J; Otsuka M
    Biomed Mater Eng; 2008; 18(6):377-85. PubMed ID: 19197114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.
    Cafini F; Sevillano D; Alou L; Gómez-Aguado F; Corcuera MT; González N; Guinea J; Prieto J
    Rev Esp Quimioter; 2012 Mar; 25(1):47-55. PubMed ID: 22488542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining potential of PMMA as a depot for rifampin to treat recalcitrant orthopaedic infections.
    Shiels SM; Tennent DJ; Akers KS; Wenke JC
    Injury; 2017 Oct; 48(10):2095-2100. PubMed ID: 28842287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections.
    Sahraoui L; Chiadmi F; Schlatter J; Toledano A; Cisternino S; Fontan JE
    Am J Health Syst Pharm; 2006 Aug; 63(15):1423-6. PubMed ID: 16849707
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial release kinetics from polymethylmethacrylate in a novel continuous flow chamber.
    Perry AC; Rouse MS; Khaliq Y; Piper KE; Hanssen AD; Osmon DR; Steckelberg JM; Patel R
    Clin Orthop Relat Res; 2002 Oct; (403):49-53. PubMed ID: 12360007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.